Taro Pharmaceutical Industries News

Taro Pharmaceutical Industries | SC 13E3/A: Schedule filed to report going private transactions (Amendment)

May 14 20:24

Taro Pharmaceutical Industries | SC 13E3/A: Schedule filed to report going private transactions (Amendment)

May 8 21:33

Taro Pharmaceutical Industries | SC 13E3/A: Schedule filed to report going private transactions (Amendment)

Apr 15 18:23

Taro Pharmaceutical Industries | SC 13E3/A: Schedule filed to report going private transactions (Amendment)

Mar 21 04:33

Taro Pharmaceutical Industries | SC 13E3/A: Schedule filed to report going private transactions (Amendment)

Mar 11 18:21

Taro Pharmaceutical Industries | SC 13E3: Schedule filed to report going private transactions

Feb 15 21:42

Taro Pharmaceutical Industries | 6-K: Report of foreign private issuer (related to financial reporting)

Jan 26 22:04

Taro Pharmaceutical Industries | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Jan 17 13:00

Taro Pharmaceutical Industries | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-SUN PHARMACEUTICAL INDUSTRIES LTD.(78.48%),DILIP S. SHANGHVI(78.48%), etc.

Jan 17 13:00

Taro Pharmaceutical Industries | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Jan 4 13:00

Taro Pharmaceutical Industries | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Dec 12, 2023 05:31

Taro Pharmaceutical Industries | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-SUN PHARMACEUTICAL INDUSTRIES LTD.(78.48%),DILIP S. SHANGHVI(78.48%), etc.

Dec 12, 2023 05:30

Taro Pharmaceutical Industries | 6-K: Report of foreign private issuer (related to financial reporting)

Nov 18, 2023 05:30

Taro Pharmaceutical Industries | 6-K: Report of foreign private issuer (related to financial reporting)

Oct 27, 2023 21:00

Taro Pharmaceutical Industries | 6-K: Report of foreign private issuer (related to financial reporting)

Jul 27, 2023 22:00

Taro Pharmaceutical Industries | 20-F: FY2023 Annual Report

Jun 30, 2023 04:32

Taro Pharmaceutical Industries | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Jun 29, 2023 05:00

Taro Pharmaceutical Industries | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Jun 1, 2023 05:00

Taro Pharmaceutical Industries | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)

May 27, 2023 05:01

Taro Pharmaceutical Industries | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

May 27, 2023 05:00